[go: up one dir, main page]

TR201100150A2 - Water soluble dosage forms - Google Patents

Water soluble dosage forms

Info

Publication number
TR201100150A2
TR201100150A2 TR2011/00150A TR201100150A TR201100150A2 TR 201100150 A2 TR201100150 A2 TR 201100150A2 TR 2011/00150 A TR2011/00150 A TR 2011/00150A TR 201100150 A TR201100150 A TR 201100150A TR 201100150 A2 TR201100150 A2 TR 201100150A2
Authority
TR
Turkey
Prior art keywords
dosage forms
water soluble
soluble dosage
eferevesan
acarose
Prior art date
Application number
TR2011/00150A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/00150A priority Critical patent/TR201100150A2/en
Priority to EP12707405.2A priority patent/EP2661252A1/en
Priority to PCT/TR2012/000003 priority patent/WO2012093972A1/en
Publication of TR201100150A2 publication Critical patent/TR201100150A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş akarboz içeren eferevesan formdaki farmasötik bileşimlere ve bu bileşimlerim diyabet, adipozite ve hiperlipidemide kullanımına yöneliktir.The present invention is directed to pharmaceutical compositions in acarose-containing eferevesan form and their use in diabetes, adiposity and hyperlipidemia.

TR2011/00150A 2011-01-06 2011-01-06 Water soluble dosage forms TR201100150A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2011/00150A TR201100150A2 (en) 2011-01-06 2011-01-06 Water soluble dosage forms
EP12707405.2A EP2661252A1 (en) 2011-01-06 2012-01-06 Water soluble dosage forms
PCT/TR2012/000003 WO2012093972A1 (en) 2011-01-06 2012-01-06 Water soluble dosage forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/00150A TR201100150A2 (en) 2011-01-06 2011-01-06 Water soluble dosage forms

Publications (1)

Publication Number Publication Date
TR201100150A2 true TR201100150A2 (en) 2012-07-23

Family

ID=45809558

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/00150A TR201100150A2 (en) 2011-01-06 2011-01-06 Water soluble dosage forms

Country Status (3)

Country Link
EP (1) EP2661252A1 (en)
TR (1) TR201100150A2 (en)
WO (1) WO2012093972A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
WO2013115745A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin)
WO2013115742A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical composition comprising alpha-glucosidase inhibitor
WO2013115746A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A production method for (effervescent) pharmaceutical compositions comprising an alpha - glucosidase inhibitor (miglitol) and metformin
WO2014036528A2 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
CN104013590A (en) * 2014-05-09 2014-09-03 万特制药(海南)有限公司 Acarbose-containing medicinal composition and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347782C3 (en) 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Amino sugar derivatives, processes for their preparation and medicaments containing these compounds
DE19802700A1 (en) * 1998-01-24 1999-07-29 Bayer Ag Preparation of fast-dissolving tablets for controlling blood sugar levels
DE19860698A1 (en) * 1998-12-30 2000-07-06 Hexal Ag New pharmaceutical composition
JP4993246B2 (en) * 2005-06-10 2012-08-08 日医工株式会社 Method for formulating acarbose-containing tablets with excellent stability over time
CN101411715B (en) * 2007-10-19 2012-03-28 杭州华东医药集团生物工程研究所有限公司 Pharmaceutical composition containing acarbose
RU2010128019A (en) * 2007-12-08 2012-01-20 Байер Шеринг Фарма Акциенгезельшафт (DE) ORAL DISPERSABLE TABLET
EP2563329B1 (en) * 2010-04-27 2017-04-12 Bayer Intellectual Property GmbH Orally disintegrating tablet containing acarbose

Also Published As

Publication number Publication date
EP2661252A1 (en) 2013-11-13
WO2012093972A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
JOP20180103A1 (en) Pharmaceutical composition
MX376058B (en) USE OF LONG-ACTING GLP-1 PEPTIDES.
EA201401077A1 (en) BISPECIFIC ANTIBODIES TO HUMAN TWEAK AND HUMAN IL17 AND THEIR APPLICATION
GT201400147A (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND ITS USE
GB201106743D0 (en) Novel compounds
EA201401204A1 (en) ANTIBODIES TO IL-23P19
EA201992133A1 (en) PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
BR112014031310A2 (en) anti-pcsk9 antibodies, formulations, dosage and methods of use
EA201390804A1 (en) DOSAGE FORM LACOSAMIDE FOR ADMISSION ONCE IN DAY
EA201400579A1 (en) ANTIBODIES TO IL-36R
EA201891433A3 (en) COMPOSITION ANTIBODIES AND THERAPEUTIC REGIMES
EA201391773A1 (en) CELLS-PRECURSORS OF THE MESODERMAL LINE
EA201590807A1 (en) STABLE IMPRESSIONAL MICRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION
MY173521A (en) Trpv4 antagonists
BR112014010290A2 (en) pharmaceutical composition, methods, compositions and uses
EA201590731A1 (en) ANTIBODIES TO HEMAGGLUTININ AND METHODS OF APPLICATION
BR112015002824A2 (en) compound, use of a compound, pharmaceutical composition, and combination pharmaceutical product.
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
CL2014003525A1 (en) Pharmaceutical composition comprising fimasartan, hydrochlorothiazide and a binder; preparation procedure; its use in the treatment of hypertension.
CL2012003322A1 (en) Compounds derived from substituted benzamide; pharmaceutical composition; and use in the treatment of cancer.
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
TR201100150A2 (en) Water soluble dosage forms
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL